Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls

Table 1 CCND1 A870G genotype distribution and allele frequency in cases and controls

Author and year	Ethnicity	Method	Genotype ( N )						P HWE controls
			Case			Control
			GG	GA	AA	GG	GA	AA
Wang et al. [10]	Japanese	PCR-RFLP	55	102	57	75	139	40	0.065
Mandal et al. [24]	Indians	PCR-RFLP	38	65	89	58	93	73	0.013
Comstock et al. [21]	African-Americans	Taqman	387	258	30	374	246	27	0.086
Comstock et al. [21]	Latinos	Taqman	212	313	118	214	315	117	0.954
Comstock et al. [21]	Japanese	Taqman	121	233	103	126	229	112	0.691
Comstock et al. [21]	Native Hawaiians	Taqman	14	40	17	12	32	24	0.814
Comstock et al. [21]	European Americans	Taqman	117	242	97	134	225	90	0.800
Comstock et al. [21]	Australians	Taqman	241	422	166	225	354	160	0.349
Kibel et al. [22]	Americans	Pyrosequencing	56	88	40	54	100	62	0.285
Koike et al. [23]	Japanese	PCR-RFLP	22	54	23	21	73	21	0.004

HWE, Hardy-Weinberg equation; PCR-RFLP, Polymerase chain reaction restriction fragment length polymorphism.

ISSN: 1477-7819